D-0244-2019 Class II Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
November 21, 2018
Initiation Date
September 27, 2018
Termination Date
October 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,362 vials

Product Description

Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Distribution Pattern

Product was distributed throughout the United States, including Hawaii and Puerto Rico.

Code Information

Lot # 31323147B, exp. date 01/2019